191 related articles for article (PubMed ID: 10417757)
1. HLA-A alleles of patients with pyothorax-associated lymphoma: anti-Epstein-Barr virus (EBV) host immune responses during the development of EBV latent antigen-positive lymphomas.
Kanno H; Ohsawa M; Hashimoto M; Iuchi K; Nakajima Y; Aozasa K
Int J Cancer; 1999 Aug; 82(5):630-4. PubMed ID: 10417757
[TBL] [Abstract][Full Text] [Related]
2. Low frequency of HLA-A*0201 allele in patients with Epstein-Barr virus-positive nasal lymphomas with polymorphic reticulosis morphology.
Kanno H; Kojya S; Li T; Ohsawa M; Nakatsuka S; Miyaguchi M; Harabuchi Y; Aozasa K
Int J Cancer; 2000 Jul; 87(2):195-9. PubMed ID: 10861473
[TBL] [Abstract][Full Text] [Related]
3. Expression of Epstein-Barr virus latent infection genes and oncogenes in lymphoma cell lines derived from pyothorax-associated lymphoma.
Kanno H; Yasunaga Y; Ohsawa M; Taniwaki M; Iuchi K; Naka N; Torikai K; Shimoyama M; Aozasa K
Int J Cancer; 1996 Jul; 67(1):86-94. PubMed ID: 8690530
[TBL] [Abstract][Full Text] [Related]
4. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521
[TBL] [Abstract][Full Text] [Related]
6. Mechanism for the development of pyothorax-associated lymphoma.
Kanno H; Aozasa K
Pathol Int; 1998 Sep; 48(9):653-64. PubMed ID: 9778104
[TBL] [Abstract][Full Text] [Related]
7. Sequences of cytotoxic T-lymphocyte epitopes in the Epstein-Barr virus (EBV) nuclear antigen-3B gene in a Japanese population with or without EBV-positive lymphoid malignancies.
Kanno H; Nakatsuka S; Iuchi K; Aozasa K
Int J Cancer; 2000 Nov; 88(4):626-32. PubMed ID: 11058881
[TBL] [Abstract][Full Text] [Related]
8. Production of the immunosuppressive cytokine interleukin-10 by Epstein-Barr-virus-expressing pyothorax-associated lymphoma: possible role in the development of overt lymphoma in immunocompetent hosts.
Kanno H; Naka N; Yasunaga Y; Iuchi K; Yamauchi S; Hashimoto M; Aozasa K
Am J Pathol; 1997 Jan; 150(1):349-57. PubMed ID: 9006350
[TBL] [Abstract][Full Text] [Related]
9. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
Gavioli R; De Campos-Lima PO; Kurilla MG; Kieff E; Klein G; Masucci MG
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5862-6. PubMed ID: 1321426
[TBL] [Abstract][Full Text] [Related]
10. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.
Murray RJ; Wang D; Young LS; Wang F; Rowe M; Kieff E; Rickinson AB
J Virol; 1988 Oct; 62(10):3747-55. PubMed ID: 2843672
[TBL] [Abstract][Full Text] [Related]
12. Role of an immunosuppressive cytokine, interleukin-10, in the development of pyothorax-associated lymphoma.
Kanno H; Naka N; Yasunaga Y; Aozasa K
Leukemia; 1997 Apr; 11 Suppl 3():525-6. PubMed ID: 9209445
[TBL] [Abstract][Full Text] [Related]
13. HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1.
Stuber G; Dillner J; Modrow S; Wolf H; Székely L; Klein G; Klein E
Int Immunol; 1995 Apr; 7(4):653-63. PubMed ID: 7547693
[TBL] [Abstract][Full Text] [Related]
14. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.
Murray RJ; Kurilla MG; Brooks JM; Thomas WA; Rowe M; Kieff E; Rickinson AB
J Exp Med; 1992 Jul; 176(1):157-68. PubMed ID: 1319456
[TBL] [Abstract][Full Text] [Related]
15. Appearance of a different clone of Epstein-Barr virus genome in recurrent tumor of pyothorax-associated lymphoma (PAL) and a mini-review of PAL.
Kanno H; Ohsawa M; Iuchi K; Nakatsuka S; Yamamoto S; Nishioka M; Aozasa K
Leukemia; 1998 Aug; 12(8):1288-94. PubMed ID: 9697886
[TBL] [Abstract][Full Text] [Related]
16. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.
de Campos-Lima PO; Levitsky V; Brooks J; Lee SP; Hu LF; Rickinson AB; Masucci MG
J Exp Med; 1994 Apr; 179(4):1297-305. PubMed ID: 7511684
[TBL] [Abstract][Full Text] [Related]
17. EBV and malignant lymphoma with special emphasis on pyothorax-associated lymphoma.
Aozasa K; Kanno H; Miwa H; Tomita Y
Curr Top Microbiol Immunol; 2001; 258():103-20. PubMed ID: 11443856
[No Abstract] [Full Text] [Related]
18. T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
Jäger M; Benninger-Döring G; Prang N; Sylla BS; Laumbacher B; Wank R; Wolf H; Schwarzmann F
Int J Cancer; 1998 May; 76(5):694-701. PubMed ID: 9610728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]